|
KDM4A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.418420E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.614400E-02 |
| Normal-vs-Stage2 |
2.011600E-01 |
| Normal-vs-Stage3 |
5.380800E-01 |
| Normal-vs-Stage4 |
2.055400E-03 |
| Stage1-vs-Stage2 |
7.494400E-01 |
| Stage1-vs-Stage3 |
4.050800E-01 |
| Stage1-vs-Stage4 |
5.853900E-02 |
| Stage2-vs-Stage3 |
7.142400E-01 |
| Stage2-vs-Stage4 |
8.594200E-02 |
| Stage3-vs-Stage4 |
4.181800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.964500E-02 |
| Normal-vs-AfricanAmerican |
1.571790E-01 |
| Normal-vs-Asian |
8.021200E-01 |
| Caucasian-vs-AfricanAmerican |
7.936600E-01 |
| Caucasian-vs-Asian |
4.824800E-01 |
| AfricanAmerican-vs-Asian |
4.837800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.399800E-03 |
| Normal-vs-Female |
1.621350E-01 |
| Male-vs-Female |
6.833900E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.589400E-01 |
| Normal-vs-Extreme_Weight |
3.144700E-03 |
| Normal-vs-Obese |
8.626100E-02 |
| Normal-vs-Extreme_Obese |
6.551800E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.301410E-01 |
| Normal_Weight-vs-Obese |
4.617200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.694800E-01 |
| Extreme_Weight-vs-Obese |
2.464800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.526800E-01 |
| Obese-vs-Extreme_Obese |
5.237800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.858600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.829200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.270100E-02 |
| Normal-vs-Age(81-100Yrs) |
1.914590E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.091800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.463040E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.957810E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.650800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.139200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.921000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.272300E-02 |
| Normal-VS-Type2 PRCC |
2.995000E-01 |
| Normal-VS-KIRP CIMP |
2.765600E-01 |
| Normal-VS-Unclassified PRCC |
7.481600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.773000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.326200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.878020E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.207000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.919600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.334800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.733600E-02 |
| Normal-vs-N1 |
8.020000E-01 |
| Normal-vs-N2 |
8.241800E-01 |
| N0-vs-N1 |
7.080000E-02 |
| N0-vs-N2 |
5.842400E-01 |
| N1-vs-N2 |
8.034400E-01 |
|
|
